InnospecIOSP +0.54%76 EBIT per Share is $5.82 as of Mar. 2026. GuruFocus rates IOSP with a GF Score™ of 76/100 and a GF Value™ of $94.71 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,339 Chemicals companies, Innospec ranks worse than 56.09% on this metric.
Innospec's EBIT per Share for the
three
months ended in Mar. 2026 was $1.28.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $5.82.
During the past 12 months, the average EBIT per Share Growth Rate of Innospec was -15.50% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -5.90% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 13.60% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 4.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Innospec's EBIT per Share or its related term are showing as below:
IOSP'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -40 Med: 5.5 Max: 57.9
Current: -5.9
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Innospec was 57.90% per year. The lowest was -40.00% per year. And the median was 5.50% per year.
IOSP's 3-Year EBIT Growth Rate is ranked worse than 56.09% of 1339
companies
in the Chemicals industry
Industry Median: -1.2
vs IOSP: -5.90
Innospec's EBIT for the
three
months ended in Mar. 2026 was $32 Mil.
Innospec (NAS:IOSP) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Innospec EBIT per Share Related Terms
Innospec EBIT per Share Historical Data
* Premium members only.
The historical data trend for Innospec's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.82
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innospec (IOSP) has a EBIT per Share of $5.82 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Innospec and its competitors. According to the industry distribution chart, Innospec ranks #751 out of 1339 companies in the Chemicals industry, placing it in the top 56.1%.
Is Innospec's EBIT per Share too high?
Innospec's current EBIT per Share is $5.82. Based on the distribution chart, Innospec ranks #751 out of 1339 companies in the Chemicals industry, which is below the industry midpoint. Overall, Innospec has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Innospec's EBIT per Share compare to MTX and ODC?
According to the Chemicals industry distribution chart, Innospec ranks #751 out of 1339 companies for EBIT per Share. This places Innospec in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Innospec and its competitors. Innospec's current EBIT per Share is $5.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innospec stock overvalued right now?
Based on GuruFocus' analysis, Innospec (IOSP) is currently considered Modestly Undervalued. The stock's GF Value™ is $94.71, compared to a current price of $81.77 — trading 13.7% below its estimated fair value. The current EBIT per Share is $5.82. Innospec's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Innospec (IOSP), the current EBIT per Share is $5.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Innospec (IOSP) Overvalued in 2026?
Based on GuruFocus' analysis, Innospec stock appears to be undervalued.
The current stock price of $81.77 is trading 13.7% below its estimated GF Value™ of $94.71.
GuruFocus considers Innospec to be Modestly Undervalued.
Key valuation signals for IOSP:
EBIT per Share: $5.82
GF Value™: $94.71 vs. price of $81.77 (13.7% below fair value)
No single metric tells the full story. See the IOSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
76GF Score
Get the complete analysis for IOSP
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOSP has been successfully added to your 
